Source:http://linkedlifedata.com/resource/pubmed/id/16537724
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
13
|
| pubmed:dateCreated |
2006-4-5
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
1538-3598
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:day |
5
|
| pubmed:volume |
295
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1579-80
|
| pubmed:dateRevised |
2006-11-7
|
| pubmed:meshHeading | |
| pubmed:year |
2006
|
| pubmed:articleTitle |
Fondaparinux in ST-segment elevation myocardial infarction: the drug, the strategy, the environment, or all of the above?
|
| pubmed:publicationType |
Editorial,
Comment
|